David R. Thomas

EAU Guidelines on Benign Prostatic Hyperplasia (BPH)

Jean de la Rosette, Gerasimos Alivizatos, Stephan Madersbacher et al. · European Urology · 2001 · 324 citations

Benign Prostatic Hyperplasia, Urology, Prostatic Disease

Characterization of SB‐269970‐A, a selective 5‐HT₇ receptor antagonist

Jim J. Hagan, Gary Price, Nigel Deeks et al. · British Journal of Pharmacology · 2000 · 281 citations · Full text

A Novel, Potent, and Selective 5-HT₇Antagonist:  (<i>R</i>)-3-(2-(2-(4-Methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970)

Peter J. Lovell, Steven M. Bromidge, Steven Dabbs et al. · Journal of Medicinal Chemistry · 2000 · 248 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Pharmaceutical Science +14

<i>In vitro</i>and<i>in vivo</i>profile of SB 206553, a potent 5‐HT_2C/5‐HT_2Breceptor antagonist with anxiolytic‐like properties

G.A. Kennett, Martyn Wood, Fiona Bright et al. · British Journal of Pharmacology · 1996 · 240 citations · Full text

Nutritional Management in Long-Term Care: Development of a Clinical Guideline

David R. Thomas, W. Ashmen, John E. Morley et al. · The Journals of Gerontology Series A · 2000 · 220 citations · Full text